Mercury Group PLC
09 January 2008
9 January 2008
Mercury Group Plc
(the 'Company')
Further re: Acquisition of Smith Melzack Pepper Angliss Limited
The Company announces that it has entered into a Settlement Agreement with the
vendors of Smith Melzack Pepper Angliss Limited ('SMPA') ('the Vendors'), which
was acquired by the Company on 28 February 2005.
Under the terms of the original sale and purchase agreement, the Vendors were
entitled to receive, under certain circumstances, deferred consideration and
further deferred consideration.
In November 2006, the Company notified the Vendors of certain claims for breach
of warranty relating to PAYE claims ('the PAYE Claim').
The Company and the Vendors have agreed that in settlement of the PAYE Claim and
any other warranty claims whether now or in the future, certain of the
entitlement of the Vendors to the deferred consideration and the further
deferred consideration shall be set-off against the PAYE Claim, and the final
amount of the deferred consideration and further deferred consideration is
£182,000 to be satisfied as follows:
(a) as to 50 per cent. of such sum by the issue and allotment to the Vendors of,
in aggregate, 4,550,000 ordinary shares in the issued share capital of the
Company ('Deferred Consideration Shares'); and
(b) as to the remaining 50 per cent. by the issue of £91,000 in nominal amount
of convertible unsecured loan stock ('Loan Stock').
The Loan Stock is convertible into ordinary shares in the Company at any time up
to the first anniversary of issue at the rate of 50 ordinary shares for every £1
nominal of Loan Stock. If the Loan Stock is not converted by such time, it shall
be repaid on the first anniversary of issue, together with interest accrued. The
Loan Stock will carry interest of 1.5 per cent. over three month LIBOR payable
quarterly in arrears.
The number of Deferred Consideration Shares and the nominal amount of the Loan
Stock shall be increased in equal proportions if and to the extent that the
amount paid by the Company in full and final settlement of the PAYE Claim is
less than £110,560. Any further ordinary shares will be issued at a price of 2p
per share and any Loan Stock will be issued at par.
Ronnie Franks, Stuart Sandler, Clive Orman, Alan Kleinman, Paul Vernon-Smith and
Colin Povey, who are directors of the Company and/or SMPA, comprise the Vendors.
Accordingly, the Settlement Agreement is classified as a related party
transaction under the AIM Rules. The independent directors consider, having
consulted with John East & Partners Limited, that the terms of the transaction
are fair and reasonable insofar as the shareholders of Mercury are concerned.
Application will be made for 4,550,000 ordinary shares to be admitted to trading
on the AIM Market and dealings are expected to commence on 14 January 2008.
Enquiries:
Mercury Group Plc
George Kynoch - Chairman 020 7343 4000
John East & Partners Limited
David Worlidge 020 7628 2200
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.